Trial Profile
A retrospective study of first line treatments with or without Pemetrexed and with or without Cisplatin in patients with malignant pleural mesothelioma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary) ; Carboplatin; Doxorubicin; Etoposide; Gemcitabine; Mitoxantrone; Paclitaxel
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 01 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology